Regulatory elements of the leukaemia inhibitory factor (LIF) promoter in murine bone marrow stromal cells

Leukaemia inhibitory factor (LIF) plays an important role as a haematopoietically active cytokine, As described earlier in a murine model, interleukin 1 (IL-I) induced LIF mRNA and protein expression. We utilized the murine cell line +/+-1.LDA11 to further define regulatory mechanisms of LIF expression in bone marrow stromal cells. The production of LIF mRNA is stimulated by IL-1 beta, TNF-alpha, and the cAMP analogue 8-bromoadenosine 3':5'-monophosphate (8BrcAMP), LIF mRNA expression is controlled at the transcriptional level. Different fragments from - 542 to - 45 bp 5' upstream of the transcriptional start site of the murine LIF gene were fused to the luciferase gene. All LIF-promoter luciferase constructs exhibited constitutive luciferase activity under serum free conditions. The level of luciferase activity decreased with LIE-promoter constructs of less than 249 bp (pLIF249) in size. When tested with the 314 bp LIF-promoter construct, incubation of stromal cells with IL-1 beta (500 U/ml) resulted in a 1.57-fold stimulation, with TNF-alpha (500 U/ml) in 2.06-fold stimulation, and with 8BrcAMP (0.5 mM) in a 3.42-fold stimulation of luciferase activity. By testing different deletion mutants we could narrow the IL-1 and TNF-alpha responsive promoter areas to the region - 249 to - 145 bp and the 8BrcAMP responsive area from - 145 to - 82 bp, Mobility shift experiments revealed that nuclear proteins from stromal cells form a DNA-protein complex by binding to the region from - 249 to - 145 hp of the LIF promoter, (C) 1999 Academic Press.